Keyword: GlaxoSmithKline (GSK)


CureVac Presents Positive Data from mRNA Trials

01.02.2023 -

German biotech CureVac has released preliminary data from its ongoing cooperation with UK drugmaker GSK on a new class of “transformative medicines” based on messenger...


GSK and Wave Life Sciences Partner on Genetics

19.12.2022 -

British pharma GSK has entered into a four-year collaboration with US clinical-stage genetic medicines company Wave Life Sciences to advance oligonucleotide therapeutics...


UK’s CPI Opens Medicines Manufacturing Innovation Center

05.12.2022 -

The UK’s Center for Process Innovation (CPI) opened its Medicines Manufacturing Innovation Center in Glasgow on Nov. 30, with the aim of accelerating new technologies in...


EU Approves Sanofi/GSK Covid Booster

11.11.2022 -

After several delays and restarts and a lengthy review by the European Medicines Agency (EMA), the Covid-19 vaccine called VidPrevtyn Beta developed by the French-British...


Pharma CEOs Take Action on Climate Change

08.11.2022 -

The CEOs of seven multinational pharmaceutical companies have announced that they are taking joint action to achieve near-term emissions reduction targets and accelerate...


GSK Names Julie Brown as first female CFO

30.09.2022 -

From next year, GSK’s top management will be led by a double female team, a pioneering move for the global pharmaceutical industry. The UK drugs giant this week announced...


Unilever Chief to Quit sooner after failed GSK Bid

27.09.2022 -

British-multinational consumer products giant Unilever has announced that its chief executive, Alan Jope, will retire at the end of 2023. The potentially earlier than...


CureVac and GSK launch Phase 1 for Covid Booster

23.08.2022 -

CureVac and GSK have announced they are launching a Phase 1 clinical trial with their modified mRNA-based Covid 19 vaccine CV051, which would be recommended as a booster...